Xeris Biopharma Holdings, Inc. — All Filings
280 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B5
425
8-K
8-K12B
ARS
CORRESP
DEF 14A
DEFA14A
EFFECT
S-3
S-4
S-4/A
S-8
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002600 | Mar 27, 2026 | — |
| 4 | FORM 4 | 0002031695-26-000006 | Mar 16, 2026 | Mar 12, 2026 |
| 4 | FORM 4 | 0001875714-26-000004 | Mar 5, 2026 | — |
| 4 | FORM 4 | 0001652410-26-000006 | Mar 4, 2026 | Mar 2, 2026 |
| 10-K | 10-K | 0001867096-26-000016 | Mar 2, 2026 | Dec 31, 2025 |
| S-8 | S-8 | 0001867096-26-000017 | Mar 2, 2026 | — |
| 144 | — | 0001950047-26-002003 | Mar 2, 2026 | — |
| 8-K | 8-K | 0001867096-26-000012 | Mar 2, 2026 | — |
| 8-K | 8-K | 0001867096-26-000010 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | FORM 4 | 0002058704-26-000004 | Feb 25, 2026 | Feb 24, 2026 |
| 4 | FORM 4 | 0001875714-26-000002 | Feb 2, 2026 | Jan 30, 2026 |
| 4 | FORM 4 | 0001553595-26-000004 | Feb 2, 2026 | Jan 30, 2026 |
| 4 | FORM 4 | 0002031695-26-000004 | Feb 2, 2026 | Jan 30, 2026 |
| 4 | FORM 4 | 0002058704-26-000002 | Feb 2, 2026 | Jan 30, 2026 |
| 4 | FORM 4 | 0001652410-26-000004 | Feb 2, 2026 | Jan 30, 2026 |
| SCHEDULE 13G/A | — | 0000102909-26-000256 | Jan 30, 2026 | — |
| 4 | FORM 4 | 0002031695-26-000002 | Jan 9, 2026 | Jan 8, 2026 |
| 144 | — | 0001950047-26-000273 | Jan 8, 2026 | — |
| 8-K | 8-K | 0001867096-26-000004 | Jan 8, 2026 | — |
| 4 | FORM 4 | 0001553595-26-000002 | Jan 6, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0001652410-26-000002 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001410781-25-000006 | Dec 19, 2025 | — |
| 144 | — | 0001950047-25-010581 | Dec 19, 2025 | — |
| 4 | FORM 4 | 0001635065-25-000004 | Dec 15, 2025 | Dec 12, 2025 |
| 144 | — | 0001950047-25-010215 | Dec 12, 2025 | — |
| 4 | FORM 4 | 0001652410-25-000005 | Dec 2, 2025 | Dec 1, 2025 |
| 8-K | 8-K | 0001867096-25-000161 | Dec 1, 2025 | — |
| 4 | FORM 4 | 0001553595-25-000004 | Nov 17, 2025 | Nov 13, 2025 |
| 144 | — | 0001950047-25-008827 | Nov 13, 2025 | — |
| 4 | FORM 4 | 0001652410-25-000003 | Nov 13, 2025 | Nov 11, 2025 |
| 144 | — | 0001950047-25-008678 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001867096-25-000159 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001867096-25-000156 | Nov 6, 2025 | — |
| 4 | FORM 4 | 0002031695-25-000006 | Oct 3, 2025 | Oct 2, 2025 |
| 4 | FORM 4 | 0002031695-25-000004 | Sep 15, 2025 | Sep 11, 2025 |
| 4 | FORM 4 | 0001867096-25-000147 | Sep 12, 2025 | Sep 11, 2025 |
| 144 | — | 0001950047-25-006996 | Sep 11, 2025 | — |
| 4 | FORM 4 | 0001867096-25-000145 | Aug 29, 2025 | Aug 28, 2025 |
| 144 | — | 0001950047-25-006482 | Aug 28, 2025 | — |
| 4 | FORM 4 | 0001867096-25-000141 | Aug 15, 2025 | Aug 13, 2025 |
| 4 | FORM 4 | 0001867096-25-000138 | Aug 13, 2025 | Aug 12, 2025 |
| 144 | — | 0001950047-25-005741 | Aug 13, 2025 | — |
| 144 | — | 0001950047-25-005670 | Aug 12, 2025 | — |
| 8-K | 8-K | 0001867096-25-000130 | Aug 7, 2025 | — |
| 10-Q | 10-Q | 0001867096-25-000136 | Aug 7, 2025 | Jun 30, 2025 |
| 4 | FORM 4 | 0001867096-25-000123 | Aug 4, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001867096-25-000124 | Aug 4, 2025 | Aug 1, 2025 |
| 4 | FORM 4 | 0001867096-25-000118 | Jun 16, 2025 | Jun 13, 2025 |
| 4 | FORM 4 | 0001867096-25-000116 | Jun 4, 2025 | — |
| 4 | FORM 4 | 0001867096-25-000114 | Jun 4, 2025 | — |